Shunt products of aminoansamycins from aas1 overexpressed mutant strain of Streptomyces sp. S35

Chin J Nat Med. 2020 Dec;18(12):952-956. doi: 10.1016/S1875-5364(20)60039-5.

Abstract

Constitutively expression of the pathway-specific activators is an effective method to activate silent gene clusters and improve natural product production. In this study, nine shunt products of aminoansamycins (1-9) were identified from a recombinant mutant strain S35-LAL by overexpressed the large-ATP-binding regulator of the LuxR family (LAL) gene aas1 in Streptomyces sp. S35. All the compounds showed no anti-microbial, anti-T3SS and cytotoxic activities.

Keywords: Aminoansamycins; Shunt products; Streptomyces sp. S35.

MeSH terms

  • Biological Products / metabolism*
  • Lactams, Macrocyclic / metabolism*
  • Multigene Family*
  • Organisms, Genetically Modified
  • Streptomyces / genetics*
  • Streptomyces / metabolism

Substances

  • Biological Products
  • Lactams, Macrocyclic